We generated single site CypA mutants (A25D, K27D, P29K and K30D) at four residues located at the secondary CA contact site (Fig. 1b) and tested their ability to disrupt CA binding biochemically and affect HIV-1 infection in cells. This evidence concerns the gene PPIA and HIV-1 infection.